Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 4 of 4 entries
View as:

A Single-And Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-890 Tablets in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06506591 Org: User:
Start: 10/26/23 End: 08/15/24 Due: 08/15/25

A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT06912165 Org: User:
Start: 12/31/24 End: 11/30/25 Due: 11/30/26

A Phase I Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-910 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06897813 Org: User:
Start: 06/30/25 End: 12/31/25 Due: 12/31/26

A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06527300 Org: User:
Start: 04/25/24 End: 12/30/25 Due: 12/30/26